BeyondSpring Inc. (BYSI) shareholders
BYSINasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.60+0.00 (+0.03%)
Close on Nov 13, 2026Market cap $24.72MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
14.7%
6M of 41M shares
Institutional holders
22
3 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Lan Huang Joint filing with Linqing Jia (15.01%) | 6,048,488 | 15.01% | 13G (passive) amendment | Dec 31, 2024 |
| Linqing Jia Joint filing with Lan Huang (12.90%) | 5,293,444 | 12.90% | 13G (passive) amendment | Jun 30, 2026 |
| Xiangmin Cui | 3,065,702 | 7.50% | 13G (passive) amendment | Sep 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BYSI | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Decheng Capital LLC | 3,800,702 | 9.24% | $6.65M | – | 0.91% |
| BlackRock, Inc. | 672,915 | 1.64% | $1.18M | +23,453 | 0.00% |
| Vanguard Capital Management LLC | 626,457 | 1.52% | $1.10M | +18,523 | 0.00% |
| Geode Capital Management, LLC | 367,740 | 0.89% | $643.91K | −7,631 | 0.00% |
| State Street Corp | 231,120 | 0.56% | $404.46K | – | 0.00% |
| Vanguard Fiduciary Trust Co | 181,196 | 0.44% | $317.09K | +1,271 | 0.00% |
| UBS Group AG | 63,032 | 0.15% | $110.31K | +61,862 | 0.00% |
| Northern Trust Corp | 62,024 | 0.15% | $108.54K | −7,244 | 0.00% |
| Meridian Wealth Management, LLC | 15,000 | 0.04% | $26.25K | – | 0.00% |
| Farther Finance Advisors, LLC | 12,773 | 0.03% | $22.35K | New | 0.00% |
| Renaissance Technologies LLC | 10,900 | 0.03% | $19.08K | −200 | 0.00% |
| Vanguard Global Advisers, LLC | 4,802 | 0.01% | $8.40K | – | 0.00% |
| Morgan Stanley | 4,570 | 0.01% | $8.00K | – | 0.00% |
| National Bank Of Canada /Fi/ | 2,875 | 0.01% | $5.03K | – | 0.00% |
| Trifecta Capital Advisors, LLC | 1,500 | 0.00% | $2.63K | – | 0.00% |
| Tower Research Capital LLC (TRC) | 1,466 | 0.00% | $2.57K | +455 | 0.00% |
| Simplex Trading, LLC | 1,165 | 0.00% | $2.04K | +301 | 0.00% |
| JPMorgan Chase & Co | 319 | 0.00% | $571 | +22 | 0.00% |
| SBI Securities Co., Ltd. | 76 | 0.00% | $133 | −11 | 0.00% |
| Barclays PLC | 19 | 0.00% | $33 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 22 | 6M | 14.7% | 3 / 7 | 4 / 0 | 0M | 0M |
| Q1 2026 | 20 | 6M | 14.6% | 5 / 4 | 3 / 7 | 1M | 0M |
| Q4 2025 | 23 | 6M | 14.6% | 6 / 4 | 7 / 1 | 1M | 0M |
| Q3 2025 | 18 | 6M | 14.4% | 2 / 6 | 4 / 0 | 0M | 0M |
| Q2 2025 | 16 | 6M | 14.6% | 3 / 2 | 5 / 3 | 1M | 0M |
| Q1 2025 | 17 | 5M | 12.9% | 4 / 1 | 3 / 3 | 0M | 0M |
| Q4 2024 | 16 | 5M | 12.8% | 3 / 2 | 3 / 3 | 0M | 0M |
| Q3 2024 | 16 | 6M | 13.5% | 2 / 0 | 5 / 3 | 0M | 0M |
| Q2 2024 | 18 | 6M | 14.0% | 2 / 3 | 5 / 6 | 0M | 1M |
| Q1 2024 | 22 | 6M | 14.4% | 4 / 6 | 3 / 3 | 1M | 0M |
| Q4 2023 | 21 | 5M | 13.3% | 3 / 4 | 4 / 7 | 5M | 0M |
| Q3 2023 | 26 | 6M | 13.7% | 3 / 1 | 8 / 2 | 5M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Lan Huang | Chief Executive Officer, Director, 10% owner | 476,760 | 1.16% | May 15, 2026 |
| Na (NL) Li | Chief Financial Officer | – | – | Jul 6, 2026 |
| Min Qiu | Chief Executive Officer | 2,498 | 0.01% | Jul 6, 2026 |
| Yingjuan June Lu | Chief Scientific Officer | 100 | 0.00% | Apr 3, 2026 |
| Jiangwen Majeti | Director | 50,914 | 0.12% | Jul 6, 2026 |
| Matthew Kirkby | Director | – | – | Apr 8, 2026 |
| Sihai Xu | Director | – | – | Apr 3, 2026 |
| Brendan Delaney | Director | – | – | Apr 3, 2026 |
| Patrick Fabbio | Director | 24,592 | 0.06% | Apr 3, 2026 |
| Xiangmin Cui | 10% owner | 4,347,239 | 10.57% | Oct 20, 2025 |
| Decheng Capital Management II (Cayman), LLC | 10% owner | – | – | Oct 20, 2025 |
| Decheng Capital Global Healthcare Fund (Master), LP | 10% owner | 4,379,743 | 10.65% | Oct 20, 2025 |
| Decheng Capital Global Healthcare GP, LLC | 10% owner | 4,159,347 | 10.12% | Oct 20, 2025 |
| Decheng Capital Management III (Cayman), LLC | 10% owner | 4,327,039 | 10.52% | Oct 20, 2025 |
| Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | – | – | Oct 20, 2025 |
| Decheng Capital China Life Sciences USD Fund II, L.P. | 10% owner | 4,028,036 | 9.80% | Oct 20, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Lan Huang Chief Executive Officer, Director, 10% owner | Mar 20, 2026 | Gift | −260,582 | – | – | 0 |
| Decheng Capital China Life Sciences USD Fund II, L.P. 10% owner | Oct 17, 2025 | Sale | −45,513 | $1.76 | $80.10K | 1,518,893 |
| Decheng Capital China Life Sciences USD Fund II, L.P. 10% owner | Oct 16, 2025 | Sale | −85,798 | $1.72 | $147.57K | 1,564,406 |
| Decheng Capital Global Healthcare GP, LLC 10% owner | Oct 15, 2025 | Sale | −17,960 | $1.65 | $29.63K | 1,650,204 |
| Decheng Capital Global Healthcare GP, LLC 10% owner | Oct 14, 2025 | Sale | −28,495 | $1.65 | $47.02K | 1,668,164 |
| Decheng Capital Global Healthcare GP, LLC 10% owner | Oct 13, 2025 | Sale | −107,361 | $1.70 | $182.51K | 1,696,659 |
| Decheng Capital Global Healthcare GP, LLC 10% owner | Oct 10, 2025 | Sale | −2,390 | $1.77 | $4.23K | 1,804,020 |
| Decheng Capital Global Healthcare GP, LLC 10% owner | Oct 9, 2025 | Sale | −3,979 | $1.81 | $7.20K | 1,806,410 |
| Decheng Capital Global Healthcare GP, LLC 10% owner | Oct 8, 2025 | Sale | −7,507 | $1.77 | $13.29K | 1,810,389 |
| Decheng Capital Management III (Cayman), LLC 10% owner | Oct 7, 2025 | Sale | −2,100 | $1.79 | $3.76K | 1,817,896 |
| Decheng Capital Management III (Cayman), LLC 10% owner | Oct 6, 2025 | Sale | −17,500 | $1.78 | $31.15K | 1,819,996 |
| Decheng Capital Management III (Cayman), LLC 10% owner | Oct 3, 2025 | Sale | −600 | $1.76 | $1.06K | 1,837,496 |
| Xiangmin Cui 10% owner | Oct 2, 2025 | Sale | −600 | $1.73 | $1.04K | 1,838,096 |
| Xiangmin Cui 10% owner | Oct 1, 2025 | Sale | −2,601 | $1.80 | $4.68K | 1,838,696 |
| Xiangmin Cui 10% owner | Sep 30, 2025 | Sale | −4,464 | $1.81 | $8.08K | 1,841,297 |
| Decheng Capital Management III (Cayman), LLC 10% owner | Sep 29, 2025 | Sale | −500 | $1.75 | $875 | 1,845,761 |
| Decheng Capital Management III (Cayman), LLC 10% owner | Sep 26, 2025 | Sale | −600 | $1.68 | $1.01K | 1,846,261 |
| Decheng Capital Management III (Cayman), LLC 10% owner | Sep 25, 2025 | Sale | −700 | $1.66 | $1.16K | 1,846,861 |
| Decheng Capital Global Healthcare GP, LLC 10% owner | Sep 24, 2025 | Sale | −2,256 | $1.68 | $3.79K | 1,847,561 |
| Decheng Capital Global Healthcare GP, LLC 10% owner | Sep 23, 2025 | Sale | −4,106 | $1.72 | $7.06K | 1,849,817 |
| Decheng Capital Global Healthcare GP, LLC 10% owner | Sep 22, 2025 | Sale | −5,410 | $1.83 | $9.90K | 1,853,923 |
| Decheng Capital Global Healthcare GP, LLC 10% owner | Sep 19, 2025 | Sale | −3,656 | $1.79 | $6.54K | 1,859,333 |
| Decheng Capital Global Healthcare GP, LLC 10% owner | Sep 18, 2025 | Sale | −5,307 | $1.74 | $9.23K | 1,862,989 |
| Decheng Capital Global Healthcare GP, LLC 10% owner | Sep 17, 2025 | Sale | −2,304 | $1.83 | $4.22K | 1,868,296 |
| Decheng Capital Global Healthcare Fund (Master), LP 10% owner | Sep 16, 2025 | Sale | −840 | $1.88 | $1.58K | 1,870,600 |
| Decheng Capital Global Healthcare Fund (Master), LP 10% owner | Sep 15, 2025 | Sale | −2,570 | $1.84 | $4.73K | 1,871,440 |
| Decheng Capital Global Healthcare Fund (Master), LP 10% owner | Sep 12, 2025 | Sale | −700 | $1.85 | $1.30K | 1,874,010 |
| Decheng Capital Management III (Cayman), LLC 10% owner | Sep 11, 2025 | Sale | −3,820 | $1.90 | $7.26K | 1,874,710 |
| Decheng Capital Management III (Cayman), LLC 10% owner | Sep 10, 2025 | Sale | −8,176 | $1.93 | $15.78K | 1,878,530 |
| Decheng Capital Management III (Cayman), LLC 10% owner | Sep 9, 2025 | Sale | −9,050 | $1.97 | $17.83K | 1,886,706 |
| Decheng Capital Management III (Cayman), LLC 10% owner | Sep 8, 2025 | Sale | −7,090 | $1.93 | $13.68K | 1,895,756 |
| Decheng Capital Management III (Cayman), LLC 10% owner | Sep 5, 2025 | Sale | −1,106 | $1.86 | $2.06K | 1,902,846 |
| Decheng Capital Management III (Cayman), LLC 10% owner | Sep 4, 2025 | Sale | −803 | $1.82 | $1.46K | 1,903,952 |
| Xiangmin Cui 10% owner | Sep 3, 2025 | Sale | −1,270 | $1.81 | $2.30K | 1,904,755 |
| Xiangmin Cui 10% owner | Sep 2, 2025 | Sale | −2,800 | $1.78 | $4.98K | 1,906,025 |
| Xiangmin Cui 10% owner | Aug 29, 2025 | Sale | −800 | $1.74 | $1.39K | 1,908,825 |
| Decheng Capital China Life Sciences USD Fund II, L.P. 10% owner | Aug 28, 2025 | Sale | −809 | $1.81 | $1.46K | 1,909,625 |
| Decheng Capital China Life Sciences USD Fund II, L.P. 10% owner | Aug 27, 2025 | Sale | −1,300 | $1.78 | $2.31K | 1,910,434 |
| Decheng Capital China Life Sciences USD Fund II, L.P. 10% owner | Aug 26, 2025 | Sale | −2,000 | $1.79 | $3.58K | 1,911,734 |
| Decheng Capital Global Healthcare Fund (Master), LP 10% owner | Aug 25, 2025 | Sale | −300 | $1.77 | $531 | 1,913,734 |
| Decheng Capital Global Healthcare Fund (Master), LP 10% owner | Aug 22, 2025 | Sale | −2,376 | $1.75 | $4.16K | 1,914,034 |
| Decheng Capital Global Healthcare Fund (Master), LP 10% owner | Aug 21, 2025 | Sale | −3,034 | $1.79 | $5.43K | 1,916,410 |
| Decheng Capital China Life Sciences USD Fund II, L.P. 10% owner | Aug 20, 2025 | Sale | −3,456 | $1.74 | $6.01K | 1,919,444 |
| Decheng Capital China Life Sciences USD Fund II, L.P. 10% owner | Aug 19, 2025 | Sale | −3,604 | $1.77 | $6.38K | 1,922,900 |
| Decheng Capital China Life Sciences USD Fund II, L.P. 10% owner | Aug 18, 2025 | Sale | −47,668 | $2.03 | $96.77K | 1,926,504 |
| Xiangmin Cui 10% owner | Aug 15, 2025 | Sale | −2,900 | $2.00 | $5.80K | 1,974,172 |
| Xiangmin Cui 10% owner | Aug 14, 2025 | Sale | −2,000 | $2.00 | $4.00K | 1,977,072 |
| Xiangmin Cui 10% owner | Aug 4, 2025 | Sale | −2,196 | $2.18 | $4.79K | 891,734 |
| Xiangmin Cui 10% owner | Jul 18, 2025 | Sale | −900 | $2.20 | $1.98K | 893,930 |
| Xiangmin Cui 10% owner | Jul 17, 2025 | Sale | −20,572 | $2.19 | $45.05K | 894,830 |
| Xiangmin Cui 10% owner | Jul 16, 2025 | Sale | −5,396 | $2.24 | $12.09K | 915,402 |
| Xiangmin Cui 10% owner | Jul 15, 2025 | Sale | −2,152 | $2.28 | $4.91K | 920,798 |
| Xiangmin Cui 10% owner | Jul 14, 2025 | Sale | −801 | $2.29 | $1.83K | 922,950 |
| Xiangmin Cui 10% owner | Jul 11, 2025 | Sale | −246 | $2.29 | $563 | 923,751 |
| Xiangmin Cui 10% owner | Jul 10, 2025 | Sale | −768 | $2.28 | $1.75K | 923,997 |
| Xiangmin Cui 10% owner | Jul 9, 2025 | Sale | −252 | $2.27 | $572 | 924,765 |
| Xiangmin Cui 10% owner | Jul 8, 2025 | Sale | −9,059 | $2.29 | $20.75K | 925,017 |
| Xiangmin Cui 10% owner | Jul 2, 2025 | Sale | −324 | $2.42 | $784 | 934,076 |
| Xiangmin Cui 10% owner | Jul 1, 2025 | Sale | −600 | $2.43 | $1.46K | 934,400 |
| Xiangmin Cui 10% owner | Jun 23, 2025 | Sale | −1,700 | $3.09 | $5.25K | 1,617,409 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of float
8.04%
2M shares short
Days to cover
41.9
At 0M shares a day
Change since last report
-3.3%
From 2M shares
Short volume, 20 days
34.5%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of BeyondSpring's stock actually held short. Settlement fails (shares not delivered on time) peaked at 95,357 shares on Aug 17, 2026 over the last 90 days.
See a number that looks wrong?